These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy. Nagashima T; Minota S J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792 [No Abstract] [Full Text] [Related]
7. Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010. Otten MH; Prince FH; Twilt M; Ten Cate R; Armbrust W; Hoppenreijs EP; Koopman-Keemink Y; Wulffraat NM; Gorter SL; Dolman KM; Swart JF; van den Berg JM; van Rossum MA; van Suijlekom-Smit LW J Rheumatol; 2011 Oct; 38(10):2258-63. PubMed ID: 21844151 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis. Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278 [No Abstract] [Full Text] [Related]
9. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis. Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168 [No Abstract] [Full Text] [Related]
10. Emerging therapies in juvenile rheumatoid/idiopathic arthritis. Passo M Curr Probl Pediatr Adolesc Health Care; 2006 Mar; 36(3):97-103. PubMed ID: 16473286 [No Abstract] [Full Text] [Related]
11. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698 [No Abstract] [Full Text] [Related]
13. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab. Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P Scand J Rheumatol; 2011 Mar; 40(2):150-2. PubMed ID: 20868307 [No Abstract] [Full Text] [Related]
14. Mycobacterium chelonae infection associated with adalimumab therapy. Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777 [No Abstract] [Full Text] [Related]
15. New treatments for juvenile idiopathic arthritis. Hashkes PJ; Friedland O; Uziel Y Isr Med Assoc J; 2002 Jan; 4(1):39-43. PubMed ID: 11802310 [No Abstract] [Full Text] [Related]
16. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195 [TBL] [Abstract][Full Text] [Related]